APPLICATION
ANDA076045
TYPE
ANDA
ORIGINAL APPROVAL
2001-08-29
LATEST ACTION
2009-06-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
LORAZEPAMPrescription
LORAZEPAM 1MG · TABLET · ORAL
LORAZEPAMPrescription
LORAZEPAM 2MG · TABLET · ORAL
LORAZEPAMPrescription
LORAZEPAM 0.5MG · TABLET · ORAL
Approval history
2009-06-29Labeling · Supplement 7AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.